Highbridge Capital Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-24,352
Closed -$2.33M 403
2018
Q3
$2.33M Sell
24,352
-76,214
-76% -$7.56M 0.06% 318
2018
Q2
$10.1M Buy
100,566
+22,000
+28% +$2.32M 0.2% 133
2018
Q1
$8.29M Buy
+78,566
New +$7.94M 0.13% 188
2016
Q4
Sell
-32,086
Closed -$2.17M 1334
2016
Q3
$2.17M Buy
+32,086
New +$2.15M 0.03% 414
2016
Q1
Sell
-7,979
Closed -$539K 1573
2015
Q4
$539K Sell
7,979
-7,426
-48% -$520K 0.01% 967
2015
Q3
$997K Buy
+15,405
New +$1.14M 0.02% 772
2015
Q2
Sell
-308,571
Closed -$21.4M 1473
2015
Q1
$21.4M Sell
308,571
-12,854
-4% -$928K 0.29% 92
2014
Q4
$24.4M Buy
321,425
+267,148
+492% +$21.1M 0.31% 99
2014
Q3
$4.39M Buy
+54,277
New +$4.53M 0.06% 317
2014
Q1
Sell
-649,285
Closed -$52.4M 1098
2013
Q4
$52.4M Sell
649,285
-213,767
-25% -$16.6M 0.63% 27
2013
Q3
$67.2M Buy
863,052
+841,013
+3,816% +$64.8M 0.71% 11
2013
Q2
$1.54M Buy
+22,039
New +$1.54M 0.02% 549

Other funds holding EMN

Highbridge Capital Management's EMN Position: Q4 2018 in Review

Highbridge Capital Management sold out of Eastman Chemical (EMN) in Q4 2018, closing a stake of 24,352 shares — an estimated $2.33M sold.

Highbridge Capital Management first reported a position in EMN in Q2 2013 and held it in 12 quarters. The position peaked at $67.2M in Q3 2013. 688 funds tracked by Wall St. Rank hold EMN as of Q4 2018.

  • Highbridge Capital Management reported no remaining Eastman Chemical position as of Q4 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 24,352 Eastman Chemical shares in Q4 2018, an estimated $2.33M.
  • Highbridge Capital Management first reported a position in Eastman Chemical in Q2 2013 and held it in 12 quarters.
  • Highbridge Capital Management's Eastman Chemical position peaked at $67.2M in Q3 2013.
  • 688 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.